แทนซาริล เทวา 100
TANZARIL TEVA 100
activeLast updated: 2026-07-29
Product & certifications 1
- FDA 1C15052/67(NG)drugคงอยู่
ตัวยาสำคัญ
- LOSARTAN POTASSIUM100.0 milligram
- ประเภทควบคุม
- ยาอันตราย
- ข้อบ่งใช้
- - Treatment of essential hypertension in adults and in children and adolescents 6-18 years of age. - Treatment of renal disease in adult patients with hypertension and type 2 diabetes mellitus with proteinuria ≥ 0.5 g/day as part of an antihypertensive treatment. - Treatment of chronic heart failure in adult patients when treatment with Angiotensin-converting enzyme (ACE) inhibitors is not considered suitable due to incompatibility, especially cough, or contraindication. Patients with heart failure who have been stabilised with an ACE inhibitor should not be switched to losartan. The patients should have a left ventricular ejection fraction ≤40% and should be clinically stable and on an established treatment regimen for chronic heart failure. - Reduction in the risk of stroke in adult hypertensive patients with left ventricular hypertrophy documented by ECG.
- รหัส ATC
- C09CA01 (losartan)
ข้อมูลตามที่ขึ้นทะเบียนกับ อย. — ไม่ใช่คำแนะนำการใช้ยา ปรึกษาเภสัชกรหรือแพทย์ก่อนใช้เสมอ
- Category
- ยาสำเร็จรูป
- Trade name
- —
- Company / Manufacturer
- บริษัท เทวา ฟาร์มา (ประเทศไทย) จำกัด
- Producer's other permits
- See all permits held by this company →
A matching registration number confirms the registration exists — it does not verify that the physical item you hold is genuine. Always compare the product and manufacturer names on the label.
Last updated: 2026-07-29 · Data aggregated from official government databases: NBTC · FDA · TISI · DBD · Dept. of Tourism · ACFSReport incorrect data